Proton MR Spectroscopic Imaging in Ataxia-Telangiectasia

Abstract

Object: Ataxia-telangiectasia (A-T) is a recessively inherited neurodegenerative disorder with prominent progressive ataxia and cerebellar degeneration, as well as manifest abnormalities of tone, posture, and movement suggesting extrapyramidal dysfunction. In this study, we tested the hypothesis that regional metabolite levels, as measured by proton magnetic resonance spectroscopic imaging, would be abnormal in patients with A-T in the posterior fossa and basal ganglia, reflecting the underlying neurodegenerative processes in these regions. Methods: Spectroscopic images of N-acetyl aspartate (NAA), choline (Cho), and creatine (Cr) were obtained in 8 patients with A-T and 8 age-matched controls. Normalized metabolite levels were compared between A-T patients and control subjects in various regions of interest, including the cerebellum, brainstem, and basal ganglia. Results: A-T patients were distinguished from controls by the profound loss of all metabolites in the cerebellar vermis (NAA, p < 0.01; Cr and Cho, p < 0.05) and a trend for decreased metabolites within the cerebellar hemispheres. No abnormalities were detected in the basal ganglia. Conclusions: Proton MR spectroscopic features in A-T closely correlate with the morphologic neuroimaging findings of posterior fossa atrophy. Although symptoms suggesting extrapyramidal dysfunction are part of the A-T phenotype, these are not associated with altered metabolite levels in the basal ganglia.

Key words

Ataxia-Telangiectasia - brain - magnetic resonance imaging - magnetic resonance spectroscopy - metabolism

References

• 1 Cabana M D, Crawford T O, Winkelstein J A, Christensen J R, Lederman H M. Consequences of the delayed diagnosis of ataxia-telangiectasia.  Pediatrics. 1998;  102 98-100
• 2 Chun H H, Gatti R A. Ataxia-telangiectasia, an evolving phenotype.  DNA Repair (Amst). 2004;  3 1187-1196
• 3 Chung E O, Bodensteiner J B, Noorani P A, Schochet Jr S S. Cerebral white-matter changes suggesting leukodystrophy in ataxia telangiectasia.  J Child Neurol. 1994;  9 31-35
• 4 Churchyard A, Stell R, Mastaglia F L. Ataxia telangiectasia presenting as an extrapyramidal movement disorder and ocular motor apraxia without overt telangiectasia.  Clin Exp Neurol. 1991;  28 90-96
• 5 Ciemins J J, Horowitz A L. Abnormal white matter signal in ataxia telangiectasia.  Am J Neuroradiol. 2000;  21 1483-1485
• 6 Crawford T O. Ataxia telangiectasia.  Semin Pediatr Neurol. 1998;  5 287-294
• 7 Crawford T O, Mandir A S, Lefton-Greif M A. et al . Quantitative neurologic assessment of ataxia-telangiectasia.  Neurology. 2000;  54 1505-1509
• 8 Farina L, Uggetti C, Ottolini A. et al . Ataxia-telangiectasia: MR and CT findings.  J Comput Assist Tomogr. 1994;  18 724-727
• 9 Goyal V, Behari M. Dystonia as presenting manifestation of ataxia telangiectasia: a case report.  Neurol India. 2002;  50 187-189
• 10 Griffiths P. Brain Scanning Technologies. International Conference on the Clinical Science of Ataxia-Telangiectasia. University of Birmingham, Birmingham, UK October 14 - 15, 2005. 
• 11 Jacobs M A, Horska A, van Zijl P C, Barker P B. Quantitative proton MR spectroscopic imaging of normal human cerebellum and brain stem.  Magn Reson Med. 2001;  46 699-705
• 12 Koepp M, Schelosky L, Cordes I, Cordes M, Poewe W. Dystonia in ataxia telangiectasia: report of a case with putaminal lesions and decreased striatal [123I]iodobenzamide binding.  Mov Disord. 1994;  9 455-459
• 13 Lucato L T, Otaduy M C, Barbosa E R. et al . Proton MR spectroscopy in Wilson disease: analysis of 36 cases.  Am J Neuroradiol. 2005;  26 1066-1071
• 14 McConville C M, Stankovic T, Byrd P J. et al . Mutations associated with variant phenotypes in ataxia-telangiectasia.  Am J Hum Genet. 1996;  59 320-330
• 15 O'Neill J, Schuff N, Marks Jr W J, Feiwell R, Aminoff M J, Weiner M W. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease.  Mov Disord. 2002;  17 917-927
• 16 Reynolds Jr N C, Prost R W, Mark L P. Heterogeneity in 1H‐MRS profiles of presymptomatic and early manifest Huntington's disease.  Brain Res. 2005;  1031 82-89
• 17 Sardanelli F, Parodi R C, Ottonello C. et al . Cranial MRI in ataxia-telangiectasia.  Neuroradiology. 1995;  37 77-82
• 18 Savitsky K, Bar-Shira A, Gilad S. et al . A single ataxia telangiectasia gene with a product similar to PI‐3 kinase.  Science. 1995;  268 1749-1753
• 19 Segewick R P, Boder E. Ataxia-telangiectasia. de Jong JMJV Handbook of Clinical Neurology. Ataxia-telangiectasia. Amsterdam; Elsevier 1991 60: 347-423
• 20 Sun X, Becker-Catania S G, Chun H H. et al . Early diagnosis of ataxia-telangiectasia using radiosensitivity testing.  J Pediatr. 2002;  140 724-731
• 21 Tavani F, Zimmerman R A, Berry G T, Sullivan K, Gatti R, Bingham P. Ataxia-telangiectasia: the pattern of cerebellar atrophy on MRI.  Neuroradiology. 2003;  45 315-319
• 22 Watanabe H, Fukatsu H, Katsuno M. et al . Multiple regional 1H‐MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker.  J Neurol Neurosurg Psychiatry. 2004;  75 103-109